Keywords: glaxo, wellcome, imitrex, appproved, food, drug, administration

Glaxo Wellcome's Imitrex appproved

Article | 19 June 1995

- The US Food and Drug Administration has granted Glaxo Wellcome marketing approval for its migraine treatment Imitrex (sumatriptan) in tablet ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Imitrex

Sumatriptan Succinate

Go to drug listing